VOYA INVESTMENT MANAGEMENT LLC
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1068837
ATLANTA, GA
Position in INDV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,805,925
+$3,459,777 QoQ
Shares Held
117,132
+165.2% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 337 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 19%
None 81%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $134,224,123 across 32 Drug Manufacturers - Specialty & Generic names. INDV ranks #11 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
370,571 | $41,111,146 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
113,293 | $19,094,401 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
442,383 | $10,887,045 | |
| 4 | VTRS |
Viatris Inc
|
471,235 | $7,483,211 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
13,289 | $7,200,378 | |
| 6 | ZTS |
Zoetis Inc.
|
89,660 | $6,442,967 | |
| 7 | ALKS |
Alkermes plc.
|
118,998 | $6,235,494 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
685,570 | $5,429,713 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,805,925 | 117,132 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,346,148 | 44,165 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||